$NeuBase Therapeutics (NBSE.US)$ NEWS NeuBase Therapeutics, ...
NEWS
NeuBase Therapeutics, Inc. (NBSE) received a notice from Nasdaq regarding non-compliance with listing requirements due to a delayed Annual Report filing. The company has until June 3, 2024, to submit a compliance plan and potentially until September 30, 2024, to regain compliance.
免責聲明：社區由Moomoo Technologies Inc.提供，僅用於教育目的。
更多信息
評論
登錄發表評論
